Method to detect differentially methylated loci with case-control designs using Illumina arrays

Genetic Epidemiology

Volumn 35, Issue 7, 2011, Pages 686-694

  Wang, Shuang ^a  

^a Columbia University ^*  (United States)

Author keywords

Case control designs; DNA methylation; Mixture model

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; FEASIBILITY STUDY; FEMALE; GENE LOCUS; HUMAN; MAJOR CLINICAL STUDY; NORMAL DISTRIBUTION; OVARY CANCER; PROBABILITY; SIMULATION;

CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; DNA METHYLATION; FEMALE; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; OVARIAN NEOPLASMS;

EID: 80054763472     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20619     Document Type: Article

References (25)

1. Baylin SB, Ohm JE. 2006. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107-116.
2. Bediaga NG, Acha-Sagredo A, Guerra I, Viguri A, Albaina C, Ruiz Diaz I, Rezola R, Alberdi MJ, Dopazo J, Montaner D, de Renobales M, Fernández AF, Field JK, Fraga MF, Liloglou T, de Pancorbo MM. 2010. DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Res 12:R77.
3. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, Doucet D, Thomas NJ, Wang Y, Vollmer E, Goldmann T, Seifart C, Jiang W, Barker DL, Chee MS, Floros J, Fan JB. 2006. High-throughput DNA methylation profiling using universal bad arrays. Genome Res 16:383-393.
4. Christensen BC, Kelsey KT, Zheng S, Houseman EA, Marsit CJ, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Kushi LH, Kwan ML, Wiencke JK. 2010. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet 6:e1001043.
5. Chung KY, Cheng IK, Ching AK, Chu JH, Lai PB, Wong N. 2011. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition. Hepatology 54:307-318.
6. Dempster AP, Laird NM, Rubin DB. 1977. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc B 39:1-38.
7. Eberth S, Schneider B, Rosenwald A, Hartmann EM, Romani J, Zaborski M, Siebert R, Drexler HG, Quentmeier H. 2010. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma. BMC Cancer 10:517.
8. Egger G, Liang G, Aparicio A, Jones PA. 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457-463.
9. Feinberg AP, Tycko B. 2004. The history of cancer epigenetics. Nat Rev Cancer 4:143-153.
10. Herman JG, Baylin SB. 2003. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054.
11. Houseman EA, Christensen BC, Yeh RF, Marsit CJ, Karagas MR, Wrensch M, Nelson HH, Wiemels J, Zheng S, Wiencke JK, Kelsey KT. 2008. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics 9:365.
12. Jones PA, Baylin SB. 2002. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428.
13. Jones PA, Laird PW. 1999. Cancer epigenetics comes of age. Nat Genet 21:163-167.
14. Kalari S, Pfeifer GP. 2010. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet 70:277-308.
15. Kerkel K, Schupf N, Hatta K, Pang D, Salas M, Kratz A, Minden M, Murty V, Zigman WB, Mayeux RP, Jenkins EC, Torkamani A, Schork NJ, Silverman W, Croy BA, Tycko B. 2010. Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet 6:e1001212.
16. Kuan PF, Wang SJ, Zhou X, Chu HT. 2010. A statistical framework for Illumina DNA methylation arrays. Bioinformatics 26:2849-2855.
17. Kulis M, Esteller M. 2010. DNA methylation and cancer. Adv Genet 70:27-56.
18. Lugthart S, Figueroa ME, Bindels E, Skrabanek L, Valk PJ, Li Y, Meyer S, Erpelinck-Verschueren C, Greally J, Löwenberg B, Melnick A, Delwel R. 2011. Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1. Blood 117:234-241.
19. Lund AH, van Lohuizen M. 2004. Epigenetics and cancer. Genes Dev 18:2315-2335.
20. Qin TR, Fu L, Sham PC, Kwong DL, Zhu CL, Chu KW, Li Y, Guan XY. 2008 Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. Int J Cancer 123:826-830.
21. Siegmund KD, Laird PW, Laird-Offringa IA. 2004. A comparison of cluster analysis methods using DNA methylation data. Bioinformatics 20:1896-1904.
22. Storey JD, Tibshirani R. 2003. Statistical significance for genome-wide studies. Proc Natl Acad Sci 100:9440-9445.
23. Strachan T, Read A. 2004. Human Molecular Genetics, 3rd edition. New York: Garland Science.
24. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, Campan M, Noushmehr H, Bell CG, Maxwell AP, Savage DA, Mueller-Holzner E, Marth C, Kocjan G, Gayther SA, Jones A, Beck S, Wagner W, Laird PW, Jacobs IJ, Widschwendter M. 2010. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 20:440-446.
25. Westfall PH, Young SS. 1993. Resampling-Based Multiple Testing: Examples and Methods for P-value Adjustment. New York: Wiley.